APC anti-mouse CD11c Antibody

Pricing & Availability
Clone
N418 (See other available formats)
Regulatory Status
RUO
Other Names
αX integrin, integrin αX chain, CR4, p150, ITGAX
Isotype
Armenian Hamster IgG
Ave. Rating
Submit a Review
Product Citations
publications
N418
C57BL/6 mouse splenocytes stained with N418 APC and PK136 PE
  • N418
    C57BL/6 mouse splenocytes stained with N418 APC and PK136 PE
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
117309 25 µg 27€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
117310 100 µg 93€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11c is a 150 kD glycoprotein also known as αX integrin, CR4, and p150. CD11c forms a αXβ2 heterodimer with β2 integrin (CD18). It is primarily expressed on dendritic cells, NK cells, a subset of intestinal intraepithelial lymphocytes (IEL), and some activated T cells. The αXβ2 integrin plays an important role in cell-cell contact by binding its ligands: iC3b, fibrinogen, and CD54.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
Mouse spleen dendritic cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD11c antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation3, immunohistochemical staining of acetone-fixed frozen sections3, immunofluorescence microscopy5, 9 (Alexa Fluor® 488 conjugated N418 was used for IHC in frozen sections10), and spatial biology (IBEX)22,23.

Application References
  1. Granucci F, et al. 1997. J. Immunol. 159:1794.
  2. Stokes RW, et al. 1998. J. Immunol. 160:5514.
  3. Metlay JP, et al. 1990. J. Exp. Med. 171:1753. (IHC, IP)
  4. Ma XT, et al. 2006. Cancer Research 66:1169.
  5. Chin RK, et al. 2006. J. Immunol. 177:290. (IF)
  6. Cervantes-Barragan L, et al. 2007. Blood 109:1131. (FC) PubMed
  7. Turnquist HR, et al. 2007. J. Immunol. 178:7018. (FC) PubMed
  8. Benson MJ, et al. 2007. J. Exp. Med. doi:10.1084/jem.20070719. (FC) PubMed
  9. You Y, et al. 2009. J. Immunol. 182:7343. (IF) PubMed
  10. Roland CL, et al. 2009. Mol. Cancer Res. 8:1761. (IHC, FC) PubMed
  11. Wikstrom M, et al.2006. J. Immunol. 177:913. PubMed
  12. Pericolini E, et al. 2008. J. Leukocyte Biol. 83:1286. PubMed
  13. Randall LM, et al. 2008. Infect. Immun.76:3312. PubMed
  14. Fahlen-Yrild L, et al. 2009. J. Immunol. 183:5032. PubMed
  15. Osterholzer JJ, et al. 2009. J. Immunol. 183:8044. PubMed
  16. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  17. Eisenach PA, et al. 2010. J Cell Sci. 123:4182. PubMed
  18. Leppin K, et al. 2014. Invest. Ophthalmol. Vis. Sci. 55:3603. PubMed
  19. Sakai F, et al. 2014. PLoS One. 9:105370. PubMed
  20. Gibbins JD, et al. 2014. Blood. 124:2953. PubMed
  21. White CE, et al. 2015. J Immunol. 194:697. PubMed
  22. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  23. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  24. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  2. Shah D, et al. 2021. Oncoimmunology. 10:1939601. PubMed
  3. Rosina M, et al. 2022. Cell Metab. 34:533. PubMed
  4. Zhu Y, et al. 2022. Nat Commun. 13:4282. PubMed
  5. Minute L, et al. 2020. J Immunother Cancer. 8:. PubMed
  6. Michalaki C, et al. 2022. Curr Protoc. 2:e505. PubMed
  7. Narusawa M, et al. 2014. Cancer Immunol Res. 2:568. PubMed
  8. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  9. Lin C, et al. 2020. Cancer Immunol Res. 632:8. PubMed
  10. Ramakrishna C, et al. 2019. Nat Commun. 10:2153. PubMed
  11. Tomida S, et al. 2019. Sci Rep. 9:10751. PubMed
  12. Kawabe T, et al. 2020. Nat Commun. 2.795833333. PubMed
  13. Kitai H, et al. 2022. BMC Biol. 20:248. PubMed
  14. Tan L, et al. 2022. Biochem Biophys Rep. 32:101351. PubMed
  15. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  16. Lefebvre MN, et al. 2021. Cell Rep. 37:109956. PubMed
  17. Jiang Q, et al. 2022. Theranostics. 12:59. PubMed
  18. Zhou J, et al. 2021. Int J Med Sci. 18:3516. PubMed
  19. Meng W, et al. 2021. JCI Insight. 6:. PubMed
  20. Miller CM, et al. 2020. J Virol. 94:00:00. PubMed
  21. Gujar R, et al. 2016. J Immunol. 197: 1650 - 1662. PubMed
  22. Nocera D, et al. 2016. J Immunol. 196: 2860 - 2869. PubMed
  23. Riva A, et al. 2013. J Immunol. 190:5961. PubMed
  24. Zhang LJ, et al. 2019. Immunity. 50:121. PubMed
  25. Shi L, et al. 2019. Theranostics. 9:4115. PubMed
  26. Page N, et al. 2018. Immunity. 48:937. PubMed
  27. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  28. Iwamoto H et al. 2018. Cell metabolism. 28(1):104-117 . PubMed
  29. Pandey S, et al. 2020. Cell Syst. 11:495. PubMed
  30. Van Den Eeckhout B, et al. 2020. NPJ Vaccines. 5:64. PubMed
  31. Sauter M, et al. 2022. iScience. 25:103677. PubMed
  32. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  33. Xia S, et al. 2014. J Leukoc Biol. 95:733. PubMed
  34. Aguilera T, et al. 2016. Nat Commun. 7:13898. PubMed
  35. Postat J et al. 2018. Immunity. 49(4):654-665 . PubMed
  36. Kim TJ, et al. 2019. Nat Commun. 10:3258. PubMed
  37. Takeda Y, et al. 2018. Innate Immun. 24:323. PubMed
  38. Kunimura K, et al. 2020. Cell Reports. 29(9):2823-2834.e7.. PubMed
  39. Liang W, et al. 2022. Methods Mol Biol. 2574:221. PubMed
  40. Wiernicki B, et al. 2022. Nat Commun. 13:3676. PubMed
  41. Zhou X, et al. 2022. Front Pharmacol. 13:887263. PubMed
  42. Chen WS, et al. 2021. Cell Rep. 37:109974. PubMed
  43. Klarquist J, et al. 2021. Cell Rep. 36:109591. PubMed
  44. Nam J, et al. 2021. Adv Sci (Weinh). 2002577:8. PubMed
  45. de Mingo Pulido , et al. 2021. Immunity. 54(6):1154-1167.e7. PubMed
  46. Coppo M, et al. 2016. Nat Commun. 7:12254. PubMed
  47. Wegmann F, et al. 2015. Clin Vaccine Immunol. 22: 1004-1012. PubMed
  48. Qian F, et al. 2015. J Mol Cell Biol. . PubMed
  49. He Y, et al. 2020. Sci Adv. 6:eaba7589. PubMed
  50. Blumenthal D, et al. 2020. eLife. 9:e55995.. PubMed
  51. Li Y, et al. 2020. Cell Rep. 30:1753. PubMed
  52. Lechner AJ et al. 2017. Cell stem cell. 21(1):120-134 . PubMed
  53. Shin M et al. 2019. Cell Chem Biol. 26(7):1036-1041 . PubMed
  54. Agelidis A, et al. 2019. Front Immunol. 10:500. PubMed
  55. Zhao J, et al. 2019. Nat Commun. 10:899. PubMed
  56. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  57. Oyarce C, et al. 2018. Front Immunol. 8:1794. PubMed
  58. Wiede F, et al. 2021. Cancer Discov. Online ahead of print. PubMed
  59. Zhou HF, et al. 2022. Front Pharmacol. 13:778755. PubMed
  60. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  61. Xiong A, et al. 2022. EBioMedicine. 83:104239. PubMed
  62. Prado C, et al. 2012. J Immunol. 188:3062. PubMed
  63. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  64. Bode K, et al. 2020. Cell Reports. 29(13):4435-4446.e9.. PubMed
  65. Wang Y, et al. 2022. Front Immunol. 13:767630. PubMed
  66. Hao F, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  67. Kulkarni NN, et al. 2021. J Biol Chem. 297:100828. PubMed
  68. Yu AI, et al. 2020. Cell Rep. 107471:31. PubMed
  69. Han C, et al. 2021. Cell Reports. 34(6):108706. PubMed
  70. O'Shea NR, Chew TS 2016. J Crohns Colitis. 10(12):1417-1427. PubMed
  71. Angelidis I, et al. 2019. Nat Commun. 10:963. PubMed
  72. Cao W, et al. 2017. Immunity. 47:1182. PubMed
  73. Best SA, et al. 2018. Cell Metab. 27:935. PubMed
  74. Sharma PK, et al. 2018. Cancer Gene Ther. 25:27. PubMed
  75. Yuan B, et al. 2021. J Immunother Cancer. 9:. PubMed
  76. Jing L, et al. 2022. Front Immunol. 13:864995. PubMed
  77. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  78. Wang B, et al. 2022. Nat Commun. 13:3821. PubMed
  79. Dos Santos Dias L, et al. 2021. PLoS Pathog. e1009324:17. PubMed
  80. Emgård J, et al. 2018. Immunity. 143:419. PubMed
  81. Fujita Y et al. 2018. Cell reports. 24(12):3296-3311 . PubMed
  82. Lin SY, et al. 2017. Autophagy. 14:778. PubMed
  83. McAlpine CS, et al. 2021. Nature. 595:701. PubMed
  84. Stump CT, et al. 2021. Open Biol. 11:210245. PubMed
  85. Dokoshi T, et al. 2021. J Clin Invest. 131:. PubMed
  86. Marjanovic ND, et al. 2020. Cancer Cell. 38(2):229-246.e13. PubMed
  87. Wang Y, et al. 2021. Sci Rep. 1.429861111. PubMed
  88. Sellau J, et al. 2016. Sci Rep. 6:28058. PubMed
  89. Gereke M, et al. 2012. J Vis Exp. 70: 4322. PubMed
  90. Madan-Lala R, et al. 2014. J Immunol. 192:4263. PubMed
  91. Bunn P, et al. 2014. J Immunol. 192:3709. PubMed
  92. Ustarroz-Cano M, et al. 2012. J Immunotoxicol. 9:374. PubMed
  93. Bak S, et al. 2008. Mol Immunol. 45:1414. PubMed
  94. Bertino P, et al. 2019. Oncoimmunology. 8:1601482. PubMed
  95. Lisk C, et al. 2020. Front Immunol. 1.329166667. PubMed
  96. Gu H, et al. 2018. Aging (Albany NY). 1.525694444. PubMed
  97. Varol D et al. 2017. Immunity. 46(6):1030-1044 . PubMed
  98. Liu D et al. 2019. Immunity. 51(1):64-76 . PubMed
  99. Matsumura T et al. 2019. Cell Rep. 27(2):561-571 . PubMed
  100. Mrdjen D et al. 2018. Immunity. 48(2):380-395 . PubMed
  101. Suryawanshi RK, et al. 2021. Nat Commun. 12:6020. PubMed
  102. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  103. Formaglio P, et al. 2021. Immunity. 54:2724. PubMed
  104. Cho YK, et al. 2022. Nat Commun. 13:4084. PubMed
  105. Zou J, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:983. PubMed
  106. Li W, et al. 2021. Front Pharmacol. 12:697483. PubMed
  107. Glauser D, et al. 2013. J Virol. 87:10828. PubMed
  108. Aebischer D, et al. 2014. PLoS One. 9:99297. PubMed
  109. Spinner C, et al. 2015. Sci Rep. 5:16269. PubMed
  110. Hrdinka M, et al. 2016. PLoS One. 11: 0162863. PubMed
  111. Li N, et al. 2021. eLife. 10:00. PubMed
  112. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  113. Gozgit JM, et al. 2021. Cancer Cell. :. PubMed
  114. Kooreman NG et al. 2018. Cell stem cell. 22(4):501-513 . PubMed
  115. Xu H, et al. 2020. Immunity. 51(4):696-708.e9.. PubMed
  116. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  117. Zhang C, et al. 2022. Nat Commun. 13:3468. PubMed
  118. Xu M, et al. 2022. Genes Dis. 9:429. PubMed
  119. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  120. Mulas F, et al. 2020. Cell Mol Immunol. . PubMed
  121. Liu M, et al. 2016. PLoS One. 11:e0166165. PubMed
  122. Markey K, et al. 2014. J Immunol. 192:5426. PubMed
  123. Cheng Y, et al. 2020. PLoS Pathog. 16:e1008569. PubMed
  124. Dmitrieva‐Posocco O et al. 2019. Immunity. 50(1):166-180 . PubMed
  125. Yadava K et al. 2019. Elife. 8 pii: e44821. PubMed
  126. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  127. Budida R, et al. 2017. Eur J Immunol. 47:1819. PubMed
  128. Niknam S, et al. 2018. Clin Cancer Res. 24:5735. PubMed
  129. Miteva K, et al. 2018. Sci Rep. 8:2820. PubMed
  130. Yang Y, et al. 2021. Sci Adv. 7:eabf6290. PubMed
  131. Kim S, et al. 2021. Elife. 10:. PubMed
  132. Gibbins J, et al. 2014. Blood. 124:2953. PubMed
  133. White C, et al. 2015. J Immunol. 194:697. PubMed
  134. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  135. Wanner-Seleznik GM, et al. 2020. Immunohorizons. 0.644444444. PubMed
  136. Liu Z, et al. 2021. Immunity. 54(2):247-258.e7. PubMed
  137. Deerhake ME, et al. 2021. Immunity. 54(3):484-498.e8. PubMed
  138. Zeng W, et al. 2021. STAR Protocols. 2(1):100361. PubMed
  139. Platteel A, et al. 2017. Vaccine.. 10.1016/j.vaccine.2017.10.044. PubMed
  140. Hu J, et al. 2019. Mol Ther Nucleic Acids. 16:650. PubMed
  141. He J, et al. 2019. J Clin Invest. 130. PubMed
  142. Kemp V, et al. 2018. Cancer Gene Ther. 26:268. PubMed
  143. Kramer K, et al. 2017. ACS Omega. 0.240972222. PubMed
  144. Liu W, et al. 2019. Epigenetics. 1.192361111. PubMed
  145. Marsh L, et al. 2009. Am J Physiol Lung Cell Mol Physiol. 296:L442. PubMed
  146. Lang V, et al. 2021. Elife. 10:. PubMed
  147. Maulloo CD, et al. 2021. Front Immunol. 12:714842. PubMed
  148. Covarrubias AJ, et al. 2020. Nat Metab. 1265:2. PubMed
  149. Li C, et al. 2021. Cell Metabolism. 33(8):1610-1623.e5. PubMed
  150. Dobson HE, et al. 2020. Mucosal Immunol. 0.901388889. PubMed
  151. Lee L, et al. 2016. PLoS One. 11:e0167693. PubMed
  152. Mainini F, et al. 2015. PLoS One. 10: 0145403. PubMed
  153. Sakai F, et al. 2014. PLoS One. 9:105370. PubMed
  154. Liu Z, et al. 2020. Cell. 178(6):1509-1525.e19.. PubMed
  155. Yahagi A, et al. 2019. RMD Open. 5:e000853. PubMed
  156. Xia P et al. 2018. Immunity. 48(4):688-701 . PubMed
  157. Nam GH, et al. 2018. Nat Commun. 9:2165. PubMed
  158. Fischer FA, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  159. Xiao Y, et al. 2022. Nat Commun. 13:758. PubMed
  160. Tukaramrao DB, et al. 2021. Cancers (Basel). 13:. PubMed
  161. Wüthrich M, et al. 2021. MBio. 12:e0201821. PubMed
  162. Schneider KM, et al. 2022. Nat Commun. 13:3964. PubMed
  163. Kohn EM, et al. 2022. J Immunol. 208:1417. PubMed
  164. Wang Y, et al. 2022. J Control Release. 349:118. PubMed
  165. Takaki H, et al. 2013. J Immunol. 191:4740. PubMed
  166. Wang H, et al. 2020. Nat Mater. 1.655555556. PubMed
  167. Ye Y, et al. 2017. Sci Immunol. 2:17. PubMed
  168. Zeng J, et al. 2018. J Immunol. 200:3407. PubMed
  169. Trinh HKT, et al. 2019. J Cell Mol Med. 23:3441. PubMed
  170. Tang Z, et al. 2021. Stem Cell Res Ther. 12:397. PubMed
  171. Zhang XW, et al. 2021. Oncoimmunology. 10:1920739. PubMed
  172. Li X, et al. 2021. Cell Death Dis. 12:314. PubMed
  173. Shan B, et al. 2020. Nat Metab. 1332:2. PubMed
  174. Zhao L, et al. 2021. STAR Protocols. 2:100732. PubMed
  175. Peng X, et al. 2016. J Cell Sci. 129: 1831 - 1842. PubMed
  176. Tozuka M, et al. 2016. J Dermatol Sci. 82: 38-45. PubMed
  177. Kalafati L, et al. 2020. Cell. 183:771. PubMed
  178. Chitu V, et al. 2020. Cell Reports. 30(9):3004-3019. PubMed
  179. Burgener SS, et al. 2019. Cell Rep. 27:3646. PubMed
  180. Yamada S, et al. 2018. Arterioscler Thromb Vasc Biol. 38:994. PubMed
  181. Chu LH, et al. 2018. Nat Commun. 9:996. PubMed
  182. Carlson PM, et al. 2021. J Immunol. 207:720. PubMed
  183. Woodring T, et al. 2022. iScience. 25:104934. PubMed
  184. Berthold N, et al. 2013. Antimicrob Agents Chemother. 57:402. PubMed
  185. Upadhya R, et al. 2016. MBio. 7: 00547-16. PubMed
  186. Onai N, et al. 2020. Int J Mol Sci. :22. PubMed
  187. Li C, et al. 2018. Cell. 174:285. PubMed
  188. Nagashima H et al. 2019. Immunity. 51(4):682-695 . PubMed
  189. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  190. Qian Z, et al. 2022. Biomedicines. 10:. PubMed
  191. Bezu L, et al. 2022. J Immunother Cancer. 10:. PubMed
  192. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  193. Vogel A, et al. 2022. Cell Rep. 38:110420. PubMed
  194. Sebina I, et al. 2016. PLoS Pathog. 12:e1005999. PubMed
  195. Zhao W, et al. 2014. Clin Vaccine Immunol. 21:74. PubMed
  196. McCauley ME, et al. 2020. Nature. 585(7823):96-101. PubMed
  197. Jiang Y, et al. 2021. Nat Commun. 12:742. PubMed
  198. Lisk C, et al. 2021. Front Immunol. 12:624197. PubMed
  199. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  200. Takahashi N, et al. 2022. Tohoku J Exp Med. 257:171. PubMed
  201. Grube J, et al. 2022. Cell Death Dis. 13:704. PubMed
  202. Liu Q, et al. 2021. Adv Mater. 33:e2102852. PubMed
  203. Sobecki M, et al. 2022. Cell Stem Cell. 29:1459. PubMed
  204. Montes de Oca M, et al. 2016. PLoS Pathog. 12: 1005398. PubMed
  205. Singhal P, et al. 2016. Proc Natl Acad Sci U S A. 113: 122 - 127. PubMed
  206. Cerina M, et al. 2017. Brain Behav Immun. 59:103-117. PubMed
  207. Kramer K, et al. 2017. Mol Ther. 25(1):62-70. PubMed
  208. Yin X, et al. 2020. Cell Rep. 33:108278. PubMed
  209. Huang WC, et al. 2020. Adv Mater. 32:e2005637. PubMed
  210. Sparber F, et al. 2019. Cell Host Microbe. 25:389. PubMed
  211. Wang S, et al. 2020. J Cell Mol Med. 24:722. PubMed
  212. Dokoshi T, et al. 2020. Cell Rep. 30:61. PubMed
  213. Van Den Eeckhout B, et al. 2020. NPJ Vaccines. 0.252777778. PubMed
  214. Dye BR, et al. 2020. Biomaterials. 234:119757. PubMed
  215. Shen H, et al. 2022. Nat Commun. 13:5013. PubMed
  216. Smith LK, et al. 2021. Elife. 10:. PubMed
  217. Harding CL, et al. 2020. Front Cell Infect Microbiol. 10:328. PubMed
  218. Li H, et al. 2022. iScience. 25:104481. PubMed
  219. Xiao Z, et al. 2022. Mater Today Bio. 15:100297. PubMed
  220. Boulch M, et al. 2021. Sci Immunol. 6:. PubMed
  221. Nicholls J, et al. 2021. Front Cell Dev Biol. 9:737880. PubMed
  222. Huang WC, et al. 2020. NPJ Vaccines. 5:23. PubMed
  223. Ryu S, et al. 2021. eLife. 0.416666666666667. PubMed
  224. Wang Y, et al. 2021. Nat Commun. 0.570833333. PubMed
  225. Aguilera TA, et al. 2020. Clin Cancer Res. 26:2972. PubMed
  226. Martins R, et al. 2016. Nat Immunol. 17:1361-1372. PubMed
  227. Pelly V, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.4. PubMed
  228. Huang WC, et al. 2020. NPJ Vaccines. 5:23. PubMed
  229. Kunishita Y, et al. 2020. Front Immunol. 11:98. PubMed
  230. Wang C, et al. 2018. Sci Transl Med. 10. PubMed
  231. Zhang B, et al. 2021. Nature. 599:471. PubMed
  232. Wang X, et al. 2021. Sci Transl Med. 13:. PubMed
  233. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  234. Gawish R, et al. 2022. Elife. 11:. PubMed
  235. Gentschev I, et al. 2012. PLoS One. 7:e37239. PubMed
  236. Dyer DP et al. 2019. Immunity. 50(2):378-389 . PubMed
  237. Sadtler K, et al. 2017. Tissue Eng Part A. 23:1044. PubMed
  238. Matisz CE, et al. 2018. Am J Pathol. 188:2589. PubMed
  239. Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed
  240. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  241. Yu L, et al. 2022. Front Immunol. 13:937331. PubMed
  242. Sethuraman SN, et al. 2020. Theranostics. 10:3397. PubMed
  243. Aggarwal N, et al. 2021. Cell Rep. 37:110170. PubMed
  244. Zhong J, et al. 2021. Commun Biol. 4:865. PubMed
  245. Akhtar MN, et al. 2020. PLoS Pathog. 16:e1009136. PubMed
  246. Shi GN, et al. 2021. Ther Adv Med Oncol. 13:1758835920987056. PubMed
  247. Rana MN, et al. 2021. Front Pharmacol. 12:643215. PubMed
  248. Cortez MA, et al. 2020. Nat Commun. 3.819444444. PubMed
  249. Brenner E, et al. 2020. Nat Commun. 11:1335. PubMed
  250. Morrissey MA, et al. 2018. Elife. 7:e36688. PubMed
  251. Kubli SP, et al. 2019. Nat Commun. 10:2678. PubMed
  252. Yáñez A et al. 2017. Immunity. 47(5):890-902 . PubMed
RRID
AB_313778 (BioLegend Cat. No. 117309)
AB_313779 (BioLegend Cat. No. 117310)

Antigen Details

Structure
Integrin α-chain, associates with integrin β2 (CD18), 150 kD
Distribution

Dendritic cells, NK cells, intestinal intraepithelial lymphocytes (IEL), some activated T cells

Function
Cellular adhesion
Ligand/Receptor
iC3b, fibrinogen
Cell Type
Dendritic cells, Epithelial cells, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen Facts Book Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Lopez-Rodriguez C, et al. 1996. J. Immunol. 156:3780.

Gene ID
16411 View all products for this Gene ID
UniProt
View information about CD11c on UniProt.org

Other Formats

View All CD11c Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD11c N418 FC
Biotin anti-mouse CD11c N418 FC,IHC-F
FITC anti-mouse CD11c N418 FC
PE anti-mouse CD11c N418 FC
Purified anti-mouse CD11c N418 FC,CyTOF®,IP,IHC
Alexa Fluor® 488 anti-mouse CD11c N418 FC
Alexa Fluor® 647 anti-mouse CD11c N418 FC,IHC,ICC,3D IHC
PE/Cyanine5 anti-mouse CD11c N418 FC
PE/Cyanine7 anti-mouse CD11c N418 FC
Brilliant Violet 605™ anti-mouse CD11c N418 FC
Alexa Fluor® 700 anti-mouse CD11c N418 FC
Pacific Blue™ anti-mouse CD11c N418 FC
APC/Cyanine7 anti-mouse CD11c N418 FC
PerCP/Cyanine5.5 anti-mouse CD11c N418 FC
PerCP anti-mouse CD11c N418 FC
Brilliant Violet 421™ anti-mouse CD11c N418 FC,IHC
Brilliant Violet 570™ anti-mouse CD11c N418 FC
Brilliant Violet 785™ anti-mouse CD11c N418 FC
Brilliant Violet 510™ anti-mouse CD11c N418 FC
Brilliant Violet 650™ anti-mouse CD11c N418 FC
Purified anti-mouse CD11c (Maxpar® Ready) N418 FC,CyTOF®
Alexa Fluor® 594 anti-mouse CD11c N418 IHC-F,3D IHC
PE/Dazzle™ 594 anti-mouse CD11c N418 FC
Brilliant Violet 711™ anti-mouse CD11c N418 FC
APC/Fire™ 750 anti-mouse CD11c N418 FC
TotalSeq™-A0106 anti-mouse CD11c N418 PG
Brilliant Violet 750™ anti-mouse CD11c N418 FC
TotalSeq™-B0106 anti-mouse CD11c N418 PG
TotalSeq™-C0106 anti-mouse CD11c N418 PG
KIRAVIA Blue 520™ anti-mouse CD11c N418 FC
Spark Blue™ 550 anti-mouse CD11c N418 FC
Spark NIR™ 685 anti-mouse CD11c N418 FC
Spark UV™ 387 anti-mouse CD11c N418 FC
Spark Red™ 718 anti-mouse CD11c N418 FC
Spark Blue™ 515 anti-mouse CD11c N418 FC
PerCP/Fire™ 806 anti-mouse CD11c N418 FC
Go To Top Version: 1    Revision Date: 11-30-2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account